Navigation Links
9 Wiley authors win Nobel Prizes
Date:10/17/2007

Hoboken, N.J., October 17, 2007John Wiley & Sons, Inc, (NYSE:JWa) (NYSE:JWb), today announced that Nobel laureates in Chemistry, Physics, Economics, and Medicine are Wiley authors.

Congratulations to Dr. Gerhard Ertl, Dr. Mario R. Capecchi, Sir Martin Evans, Dr. Albert Fert, Dr. Peter Grnberg, Leonid Hurwicz, Dr. Erik Maskin, Dr. Roger Myerson, and Dr. Oliver Smithies on this recognition of their great achievements. We are honored and proud that they are members of Wileys author community, along with more than 350 other Nobel laureates who have published with us. Collaborating with this esteemed group of Nobel laureates reflects Wileys unwavering commitment to publishing cutting-edge research and sharing it with readers around the world, said William J. Pesce, Wiley's President and Chief Executive Officer.

Dr. Gerhard Ertl, of Germany, has received the Nobel Prize in Chemistry for his studies of chemical processes on solid surfaces. Dr. Ertl is co-editor of the eight-volume Handbook of Heterogeneous Catalysis, to appear in early 2008, and serves on the editorial boards of Chemistry A European Journal and ChemPhysChem, which are published by Wiley-VCH together with numerous European Chemical Societies.

Leonid Hurwicz, Dr. Erik Maskin, and Dr. Roger Myerson, all of the USA, were awarded the Nobel Prize in Economics for laying the foundations of mechanism design theory. All three Nobel laureates write for a variety of Wiley-Blackwell journals.

Dr. Peter Grnberg, of Germany, and Dr. Albert Fert, of France, were jointly awarded the Nobel Prize in Physics for the discovery of Giant Magnetoresistance. Dr. Grnberg recently published a highly-cited review article in the Physik Journal, on behalf of Germanys Physical Society, the worlds largest physical society. With his colleagues, Dr. Fert has coauthored several articles that appear in Wiley-Blackwell journals.

Dr. Mario R. Capecchi of the USA, Sir Martin Evans of the UK, and Dr. Oli
'/>"/>

Contact: Susan Spilka
sspilka@wiley.com
201-748-6147
Blackwell Publishing Ltd.
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Publishers John Wiley & Sons Enter Into An Agreement With NASPGHAN And AASLD
2. Dr. Scott Hammer Authors Two New Guidelines for HIV Treatment
3. Authors Review Astrodome Medical Response to Hurricane Katrina
4. Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn
5. Nobel Prize for Medicine shared by Three scientists
6. Stem cell research- now Nobel Laureates join the debate
7. Nobel laureates in chemistry
8. Nobel Prize for Medicine
9. Cholesterol Mystery Solved By Nobel Laureates
10. Nobel For Ulcer-Defying Aussie Scientists
11. Aussie Nobel Prize Winners Receive Their Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...a routine dental check-up may not only prevent the...nalysis says that such screenings could end up sav...in healthcare costs for the patients. The review ...alth Technology Assessment, the international jour...
... are pretty much of a household therapy in the Uni...has revealed that these therapies have added value...ing the quality of life. In that respect, United K... health investment. “The conclusion is that if yo...
...at the University of California, San Francisco (UC... prevents the growth of brain cancer. // The compo...ate against lethal brain tumor. In animal studies ... to be potent against proliferating cancer cells. ...
... when uou're 80 years old or more might be quite b...s from a joint UC Irvine and University of Souther... mortality rates from participants of a large-scal... California retirement community. The analysis fo...
Other Medicine News:Health News:Routine Dental Check-Ups Should Include Oral Cancer Screening 2Health News:Varicose Vein Treatments Turn Out To Be A Viable Health Investment 2Health News:Varicose Vein Treatments Turn Out To Be A Viable Health Investment 3Health News:PI-103 Effective against Brain Cancer 2Health News:PI-103 Effective against Brain Cancer 3Health News:Elderly and Overweight -Not Such a Bad Combination After All 2
(Date:10/8/2008)...e, Oct. 8 /- Vical Incorporated (Nasd...data and new nonclinical data,demonstrating that t...applicable in DNA- and protein-based infectious di...Alain P. Rolland, Pharm.D., Ph.D., Vical,s,Senior ...t the data today,Wednesday, October 8, at the Wor...
(Date:10/7/2008)...as, Oct. 7 /- The Texas Cardiac Arrhy...er has been selected as one of,only a few sites in...ical,trial for a new device to treat persistent at...t, training and research center specializing in he... David,s Medical Center and,Texas Cardiovascular C...
(Date:10/7/2008)...al study of adults, VYVANSE taken once-daily signi...week, PHILADELPHIA, Oct. 7 /PRNewswire-FirstCall/...l specialty biopharmaceutical company, today,annou... of the Journal of,Clinical Psychiatry found once-...icit Hyperactivity Disorder (ADHD) symptoms in adu...
(Date:10/7/2008)...tracts highlighting CIMZIA,s long-term benefits an...ents presented at American College,of Gastroentero...tCall/ -- Data from two studies,presented this wee...gy,(ACG) Annual Meeting demonstrate that CIMZIA(R)...F alpha (Tumor Necrosis Factor alpha) - provides,s...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9New study sheds light on Gal 26 23225 3Bpagos hawk evolutionary history 641 1New study sheds light on Gal 26 23225 3Bpagos hawk evolutionary history 641 2First significant genetic finding in severe PMS or PMDD 2600 1First significant genetic finding in severe PMS or PMDD 2600 2Algorithms to reanimate the heart 2598 1Algorithms to reanimate the heart 2598 2Algorithms to reanimate the heart 2598 3Dietary calcium could possibly prevent the spread of breast cancer to bone 639 1Dietary calcium could possibly prevent the spread of breast cancer to bone 639 2
...SINESS WIRE)--Jun 25, 2007 - Neurogen,Corporation ...esults from two dose-ranging, Phase 2b clinical tr...,s proprietary insomnia agent,NG2-73, an alpha-3 ...lations were studied in each trial to determine th...ntenance of sleep,through the night without residu...
...hly potent DPP-4 inhibitor, possessing Ki of 27,pM...armaceuticals,Inc., a privately held drug discove...results of its potent, smart DPP-4 inhibitor,ARI-...n Diabetes,Association meeting in Chicago, Illinoi...y long acting, potent inhibitor of DPP-4 and,produ...
Other Medicine Technology:Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4
... your own cath lab? Worried about the high costs,...adaches of managing the ongoing business operation... service leaving you free to care for your patient...venient diagnostic facility for you and your patie...
...s exactly the same as the model SP-8800 with one b...achy mode. This mode has its own fixation targets .... It allows you to select an area on the cornea to...are to calculate averages of multiple readings in ...
...rSuite holmium laser combines excellent cutting, a...rtually bloodless procedures. It is also extremely... stones of all compositions, making it an ideal mu...is transmitted through flexible fibers, it is espe...
...rSuite holmium laser combines excellent cutting, a...rtually bloodless procedures. It is also extremely... stones of all compositions, making it an ideal mu...is transmitted through flexible fibers, it is espe...
Medicine Products: